Result of EGM and Warrantholder GM
27 Novembro 2008 - 10:07AM
UK Regulatory
RNS Number : 0817J
York Pharma plc
27 November 2008
York Pharma plc
(the "Company")
Result of EGM and Warrantholder GM
London, UK, 27 November 2008 - York Pharma plc (AIM:YRK), the pharmaceutical company focused on the field of dermatology, announces that
all of the resolutions proposed at the Company's EGM, held at 11.00 a.m. this morning, were duly passed. Furthermore, the resolution
proposed at the Company's Warrantholder General Meeting held at 11.30 a.m. this morning was also duly passed.
Further to the announcement of 28 October 2008 that the Company had conditionally placed 3,541,140 ordinary shares to raise �510,000,
dealings in 3,541,140 new ordinary shares in the Company are expected to commence on AIM on 28 November 2008.
- END -
For further information please contact:
York Pharma plc
Sue J Keast
Company Secretary
e-mail: s.keast@yorkpharma.com
Collins Stewart Europe Limited
Hugh Field/Adam Cowen +44 (0)20 7523 8350
This information is provided by RNS
The company news service from the London Stock Exchange
END
REGEAAFXAESPFFE
York Pharma (LSE:YRK)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
York Pharma (LSE:YRK)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre York Pharma da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de York Pharma Plc